Powered by: Tekkon Technologies
STARTUP NEWS EVENTS CALENDAR
These events are imported from Meetup and Eventbrite group pages. Please check links for up to date details.
WA MTP Sector Spotlight Series
31 May @ 7:30 am - 9:00 am
If you find yourself unable to attend our Spotlight in person, we would love if you could still join us virtually on Zoom.
Please use the following Zoom details to join our event at 8am:
ID: 348 336 8883
The MTPConnect WA Life Sciences Innovation Hub invites you to join the monthly WA MTP Sector Spotlight Series event.
About this event
Our monthly breakfast series is an opportunity for representatives from across the MTP sector to connect, collaborate and learn about upcoming opportunities, and hear the stories and successes of WA organisations developing health and medical innovations. Join us over a light breakfast in the last week of each month at the Harry Perkins Institute of Medical Research.
Join Brandon Capital’s Dr Mikkelsen in conversation with MTPConnect’s Dr Tracey Wilkinson for a fireside chat discussing funding and investment opportunities available to WA start-ups and SMEs through the Brandon BioCatalyst.
Tuesday 31 May 2022
Fireside chat 8:00-9:00am AWST
Ground Floor Auditorium at Harry Perkins Institute of Medical Research, 6 Verdun Street Nedlands.
7:30am Informal networking (COVID restrictions permitting) at Coffee Anatomy, ground floor of the Perkins Institute
8:00am Guided fireside chat
9:00am Event close
Featuring Brandon Capital – insights into investing in life science.
Brandon Capital is a leading life science venture capital firm, with a strong global presence supported by key partnerships and team members across the US and UK.
From early-stage seed investment through to expansion capital, Brandon Capital supports life science companies from proof-of-concept through to commercialisation.
In Australia and New Zealand, the company delivers Brandon BioCatalyst (formerly the Medical Research Commercialisation Fund), a unique collaboration of Australian superannuation funds, CSL, the Australian and New Zealand governments, Australian state governments and more than 50 leading medical research institutes and research hospitals.
Brandon BioCatalyst supports the development and commercialisation of early-stage biomedical discoveries originating from Australian and New Zealand member research organisations, providing both capital and expertise to guide the successful development of new therapies.
This unique collaboration is in serve of a single purpose: progressing the next generation of medical therapies and technology which improve health and save lives.
About our speaker Dr Helga Mikkelsen
Dr Mikkelson is an Investment Analyst at Brandon Capital, which manages the BioCatalyst (formerly the Medical Research Commercialisation Fund).
Following degrees in Chemical Engineering and Biotechnology, Helga completed her PhD in microbiology at the University of Cambridge and postdoctoral research in bacterial genetics at Imperial College London. She subsequently managed the development of anti-infective medical devices in urology at CamStent Ltd (Cambridge, UK).
Since her move to Australia in 2016, Dr Mikkelson has worked with the Telethon Kids Institute to commercialise inhaled drug treatments for respiratory disease and is a co-founder of Respirion Pharmaceuticals, which develops a new treatment for chronic lung infections in patients with cystic fibrosis.
For any queries, please get in touch with Rebekah Craggs at email@example.com
If you’d like to have your WA startup event automatically displaying on this calendar, please email firstname.lastname@example.org your Meetup or Eventbrite group/events page links.